Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
University of Toronto · University of North Carolina at Chapel Hill · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,067
total citations
- FWCI
- 49.31
- Percentile
- 100%
- References
- 36
Citations per year
Authors
7Topics & keywords
Topics
Keywords
- Exenatide
- Medicine
- Type 2 diabetes
- Open label
- Internal medicine
- Diabetes mellitus
- Randomized controlled trial
- Endocrinology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.